Drug Discovery & Development Insights by OmicsX
No Result
View All Result
  • Login
  • Register
  • Home
  • Channels
  • Startups
  • Pipeline
  • Drug Targets
  • Bio Partnering
  • Opinion
PRICING
SUBSCRIBE
  • Home
  • Channels
  • Startups
  • Pipeline
  • Drug Targets
  • Bio Partnering
  • Opinion
No Result
View All Result
Drug Discovery & Development Insights by OmicsX
No Result
View All Result

Targeted Cancer Therapies in Development – Antibodies

Insights on Monoclonal Antibodies, Bispecific Antibodies, Antibody Drug Conjugates and Fragment based Antibodies Approved & in Development.

Team OmicsX by Team OmicsX
July 1, 2021
in Antibodies, Oncology
Home Oncology Antibodies

Articles in this Series –

  • Details on 46 Approved Cancer Targeting Antibodies.
  • 112 Monoclonal Antibodies in Active Clinical Development – Developers, Pipeline, Target & Cancer Indication.
  • 200 Monoclonal Antibodies in Active Preclinical Development – Developers, Pipeline, Target & Cancer Indication.
  • Bispecific Antibodies in Active Clinical Development – Developers, Pipeline, Targets & Cancer Indication.
  • Bispecific Antibodies in Active Preclinical Development – Developers, Pipeline, Targets & Cancer Indication.
  • Antibody Drug Conjugates in Active Clinical Development – Developers, Pipeline, Targets & Cancer Indication.
  • Antibody Drug Conjugates in Active Preclinical Development – Developers, Pipeline, Targets & Cancer Indication.

Cancer Targeting Antibodies in Development

  • All
  • Monoclonal Antibodies
  • Bispecific Antibody
  • Antibody Drug Conjugate
Cancer Targeting Clinical Stage Monoclonal Antibodies in Active Development – 2021
Monoclonal Antibodies

Cancer Targeting Clinical Stage Monoclonal Antibodies in Active Development – 2021

by Team OmicsX
May 27, 2022
1

Monoclonal Antibody Name, Target, Developer, Partner, Highest Phase of Development, NCT Number, Cancer Indications etc.  

Read more
Approved Monoclonal Antibodies for Cancer Treatment

Approved Monoclonal Antibodies for Cancer Treatment

July 1, 2021
Cancer Targeting Clinical Stage Antibody Drug Conjugates in Active Development – 2021

Cancer Targeting Clinical Stage Antibody Drug Conjugates in Active Development – 2021

June 29, 2021

Cancer Targeting Pre-Clinical Stage Antibody Drug Conjugates in Active Development – 2021

June 29, 2021

Cancer Targeting Pre-Clinical Stage Monoclonal Antibodies in Active Development – 2021

June 29, 2021
Global Oncology Intelligence Global Oncology Intelligence Global Oncology Intelligence
Tags: Targeted Cancer Therapies
Share202Tweet126SendShare35
Previous Post

Cancer Targeting Small Molecule Epigenetic Drugs in Development – An Overview

Next Post

test onco deals and alliance

Next Post
Approved Small Molecule Kinase (Non-Oncology) Inhibitors

test onco deals and alliance

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

Drug Discovery & Development Insights by OmicsX

Mapping Bio-Innovations

updated.. easy.. precise... complete...

Presenting filtered comprehensive information. Gain more insights on emerging bio-business, frame strategies, grow faster & better connect with biological science community.

LEARN MORE »

  • Trending
  • Comments
  • Latest
Approved Monoclonal Antibodies for Cancer Treatment

Approved Monoclonal Antibodies for Cancer Treatment

July 1, 2021
Worldwide 73 Approved Oncology Targeting Small Molecule Kinase Inhibitors

Worldwide 73 Approved Oncology Targeting Small Molecule Kinase Inhibitors

June 30, 2021

Small Molecule Kinase Inhibitors – Preclinical Drug Developers Profiles

July 1, 2021

Global Cancer Targeting Small Molecule Kinase Inhibitors in Preclinical Development – 2021

July 3, 2021
Approved Monoclonal Antibodies for Cancer Treatment

Approved Monoclonal Antibodies for Cancer Treatment

1
Cancer Targeting Clinical Stage Monoclonal Antibodies in Active Development – 2021

Cancer Targeting Clinical Stage Monoclonal Antibodies in Active Development – 2021

1
Cancer Targeting Pre-Clinical Stage Monoclonal Antibodies in Active Development – 2021

Cancer Targeting Pre-Clinical Stage Monoclonal Antibodies in Active Development – 2021

1
Cancer Targeting Pre-Clinical Stage Monoclonal Antibodies in Active Development – 2021

Cancer Targeting Clinical Stage Bispecific Antibodies in Active Development – 2021

1
Approved Small Molecule Kinase (Non-Oncology) Inhibitors

test onco deals and alliance

May 27, 2022

Targeted Cancer Therapies in Development – Antibodies

July 1, 2021

Cancer Targeting Small Molecule Epigenetic Drugs in Development – An Overview

May 27, 2022

Global Cancer Targeting Small Molecule Epigenetic Inhibitors – 2021

June 30, 2021

Developed by OmicsX. The entirety of this site is protected by copyright © 2010–2021 HH BioTechnologies Private Ltd.

No Result
View All Result
  • Home
  • Subscription
  • Category
    • Opinion
    • Tech
  • Landing Page
  • Buy JNews
  • Support Forum
  • Pre-sale Question
  • Contact Us

Developed by OmicsX. The entirety of this site is protected by copyright © 2010–2021 HH BioTechnologies Private Ltd.

Welcome Back!

Login to your account below

Forgotten Password? Sign Up

Create New Account!

Fill the forms below to register

*By registering into our website, you agree to the Terms & Conditions and Privacy Policy.
All fields are required. Log In

Retrieve your password

Please enter your username or email address to reset your password.

Log In
This website uses cookies. By continuing to use this website you are giving consent to cookies being used. Visit our Privacy and Cookie Policy.
Are you sure want to unlock this post?
Unlock left : 0
Are you sure want to cancel subscription?